Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
[72]
RCT |
121 people |
Overall adverse effects
77% with escitalopram 89% with paroxetine Absolute numbers not reported |
|||
[72]
RCT |
121 men and women |
Ejaculation disorder
30% of men with escitalopram 14% of men with paroxetine Absolute numbers not reported |
Reported as significant P value not reported |
Effect size not calculated | paroxetine |
[72]
RCT |
121 men and women |
Decreased libido
26% with escitalopram 5% with paroxetine Absolute numbers not reported |
Reported as significant P value not reported |
Effect size not calculated | paroxetine |
[72]
RCT |
121 men and women |
Anorgasmia
26% with escitalopram 7% with paroxetine Absolute numbers not reported |
Reported as significant P value not reported |
Effect size not calculated | paroxetine |
[57]
RCT 5-armed trial |
681 people |
Anorgasmia
over 12 weeks
6/136 (5%) with escitalopram (10 mg/day) 9/139 (7%) with paroxetine (20 mg/day) |